Sepracor now part of Dainippon Sumitomo
This article was originally published in Scrip
Executive Summary
Dainippon Sumitomo Pharma (DSP) has now completed its roughly $2.6 billion acquisition of Sepracor, following a second tender offer ending on October 19th in which it raised its holding in the US firm to around 87%.